Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma.

导出原文传递

翻译打印收藏纠错

第一作者： Nicole G,Chau

第一单位： Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

作者： Nicole G,Chau ^[1] ; Yvonne Y,Li ^[1] ; Vickie Y,Jo ^[2] ; Guilherme,Rabinowits ^[1] ; Jochen H,Lorch ^[1] ; Roy B,Tishler ^[3] ; Danielle N,Margalit ^[3] ; Jonathan D,Schoenfeld ^[3] ; Don J,Annino ^[4] ; Laura A,Goguen ^[4] ; Tom,Thomas ^[4] ; Hailey,Becker ^[1] ; Tyler,Haddad ^[5] ; Jeffrey F,Krane ^[2] ; Neal I,Lindeman ^[2] ; Geoffrey I,Shapiro ^[1] ; Robert I,Haddad ^[1] ; Peter S,Hammerman ^[5]

作者单位： Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. ^[1] Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. ^[2] Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. ^[3] Division of Otolaryngology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. ^[4] Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. Peter_Hammerman@dfci.harvard.edu Robert_Haddad@dfci.harvard.edu. ^[5]